[2] Weil BR, Westby CM, Greiner JJ, et al. Elevated endothelin-1 vasoconstrictor tone in prehypertensive adults. Can J Cardiol. 2012;28(3):347-353.
[3] Redwine KM, Falkner B. Progression of prehypertension to hypertension in adolescents. Curr Hypertens Rep. 2012;14(6): 619-625.
[4] Dubsky M, Jirkovska A, Bem R, et al. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment. Diabetes Metab Res Rev. 2013;29(5):369-376.
[5] Mehta JL, Szwedo J. Circulating endothelial progenitor cells, microparticles and vascular disease. J Hypertens. 2010; 28(8):1611-1613.
[6] Du F, Zhou J, Gong R, et al. Endothelial progenitor cells in atherosclerosis. Front Biosci (Landmark Ed). 2012;17: 2327-2349.
[7] Gavin KM, Seals DR, Silver AE, et al. Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women. J Clin Endocrinol Metab. 2009; 94(9):3513-3520.
[8] Moreau KL, Hildreth KL, Meditz AL, et al. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab. 2012;97(12): 4692-4700.
[9] Pérez-López FR, Larrad-Mur L, Kallen A, et al. Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci. 2010;17(6):511-531.
[10] Herrmann JL, Abarbanell AM, Weil BR, et al. Gender dimorphisms in progenitor and stem cell function in cardiovascular disease. J Cardiovasc Transl Res. 2010; 3(2):103-113.
[11] James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
[12] Di Stefano R, Barsotti MC, Felice F, et al. Endothelial progenitor cells in prehypertension. Curr Pharm Des. 2011; 17(28):3002-3019.
[13] Fernandes T, Nakamuta JS, Magalhães FC, et al. Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis. J Hypertens. 2012;30(11):2133-2143.
[14] Urbina EM, Khoury PR, McCoy C, et al. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich). 2011;13(5):332-342.
[15] MacEneaney OJ, DeSouza CA, Weil BR, et al. Prehypertension and endothelial progenitor cell function. J Hum Hypertens. 2011;25(1):57-62.
[16] Giannotti G, Doerries C, Mocharla PS, et al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension. 2010;55(6):1389-1397.
[17] Kissel CK, Anderson TJ. Role of endothelin-1 and endothelial dysfunction in prehypertension. Can J Cardiol. 2012;28(3): 251-253.
[18] Fukuhara M, Arima H, Ninomiya T, et al. Impact of lower range of prehypertension on cardiovascular events in a general population: the Hisayama Study. J Hypertens. 2012; 30(5):893-900.
[19] Baruscotti I, Barchiesi F, Jackson EK, et al. Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase. Hypertension. 2010; 56(3):397-404.
[20] Imanishi T, Tsujioka H, Akasaka T. Endothelial progenitor cell senescence--is there a role for estrogen. Ther Adv Cardiovasc Dis. 2010;4(1):55-69.